Dr. Reddy’s Announces Launch Of D2C Website ‘Celevida Wellness’ For Diabetes
Dr. Reddy’s Laboratories Ltd., an Indian pharmaceutical company, today announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its subsidiary, Svaas Wellness Limited.
According to the Indian Council of Medical Research – India Diabetes (ICMR-INDIAB) national cross-sectional study, it is estimated that India has around 101 million people with diabetes and 136 million people with prediabetes. The company's official statement says ‘Celevida Wellness’ aims to become a one-stop solution for personalised diabetic care for Type 2 diabetic and pre-diabetic individuals.
The website will host the Celevida range of products as well as other third-party brands to offer a product portfolio that takes care of a diabetic patient’s daily nutritional requirement and at the same time fits into the complete occasion framework of the day i.e., breakfast, lunch, dinner, snacks, beverages, meal replacement, etc.
M.V. Ramana, Chief Executive Officer, of Branded Markets (India and Emerging Markets), said: “As a business, the launch of 'Celevida Wellness' strengthens our presence in the nutraceutical segment and also marks our foray into the D2C space in keeping with evolving pharma business models as we aim to reach more than 1.5 billion patients by the year 2030. Consumers are increasingly buying via mobile phones and e-commerce routes. ‘Celevida Wellness’ as a D2C route allows the company to take eligible products directly not just to more diabetic and pre-diabetic consumers, but also to health-conscious consumers.”
The official statement further revealed Celevida Wellness' plans and mentioned that it will also include features such as ‘Digital Diary’ (a content repository through which users can track their condition and nutrition intake) and on-call consultation with nutritionists.
